IL17A and hepatocellular carcinoma: In Li et al.'s study [51, 52] about the interaction between IL-17 and IFN-γ on the growth of mouse hepatoma Hepa1-6 cells (HCC), IL-17 or IFN-γ alone could significantly activate p38 MAPK and ERK1/2.